Exploring the Relationship Between Depression and Sleep Disorders
DOI:
https://doi.org/10.61173/7xj7qt80Keywords:
Depression, Sleep Disorders, Bidirectional Relationship, Evidence-Based Interventions, Neurobiological MechanismsAbstract
Depression is a pressing global public health crisis affecting approximately 380 million people worldwide, with a particularly alarming rise among adolescents. A critical yet underrecognized aspect of this disorder is its strong bidirectional link to sleep disturbances. These issues not only serve as core diagnostic symptoms of depression but also act as independent risk factors for its onset and progression. Significantly, approximately 45% to 50% of suicides worldwide are associated with individuals diagnosed with depression, underscoring the critical need to elucidate the interplay between sleep disturbances and depressive disorders to enhance clinical interventions. This paper systematically examines the reciprocal relationship between the two conditions, exploring key physiological mechanisms (HPA axis dysregulation, neurotransmitter imbalances, chronic inflammation) and psychological factors (rumination, catastrophic sleep beliefs, conditioned arousal). It also evaluates evidence-based interventions, including cognitive-behavioral therapy for insomnia (CBT-I)—which achieves 60-65% insomnia remission—and targeted pharmacotherapies (e.g., mirtazapine for insomnia-dominant depression). By synthesizing core research findings, this review aims to enhance clinical understanding of their interaction, providing actionable insights to break the cycle of poor sleep and worsening mood.
References
cognitive restructuring, with 45% maintaining remission [3] Riemann, D., et al. (2019). Sleep and depression. Lancet at 1 year [54,55]. Psychiatry, 6(10), 825-835. - MBCT: Reduces depressive relapse by 27% and im- [4] Liu, Y., et al. (2022). Cognitive impairment in MDD patients. proves sleep by targeting rumination [56]. Journal of Affective Disorders, 307, 1-8. [5] Irwin, M. R. (2021). Sleep and inflammation. Biological 5.2 Medical Interventions Psychiatry, 89(3), S45-S52. - Insomnia-Dominant Depression: Mirtazapine boosts [6] Manber, R., et al. (2020). CBT-I for depression remission. sleep efficiency by 31%; agomelatine advances melatonin JAMA Psychiatry, 77(5), 495-503.
onset [57,58]. [7] World Health Organization (WHO). (2023). Depression Fact - Hypersomnia-Dominant Depression: Bupropion reduces Sheet. Geneva: WHO.
sleep latency with no weight gain [59]. [8] World Health Organization (WHO). (2022). ICD-11 Clinical - Adjuncts: Ramelteon improves sleep onset; rTMS Descriptions for Mood Disorders. Geneva: WHO.
achieves 50–60% depression response [60,61]. [9] Kessler, R. C., et al. (2021). Duration and pervasiveness of depressive episodes. JAMA Psychiatry, 78(3), 287-298. 6. Conclusion [10] Zimmerman, M., et al. (2021). Severity specifiers in depression diagnosis. American Journal of Psychiatry, 178(5), This review examines the bidirectional depression-sleep 428-440. disorder relationship, affecting 380 million globally. [11] Fava, M., et al. (2023). Differential diagnosis of depressive Among depressed patients, 73% experience sleep disturdisorders. Journal of Clinical Psychiatry, 84(1), 22f14476. bances: insomnia (65%), REM abnormalities (70%), and [12] Global Burden of Disease Collaborative Network. (2023). circadian disorders (25-35%). Sleep efficiency strongly Global Prevalence of Depression. The Lancet, 401(10391), correlates with depression severity, highlighting sleep’s 2137-2148. critical role in mood regulation. Depression and sleep [13] Albert, P. R. (2022). Neurobiological mechanisms of sex Dean&Francis ISSN 2959-409X
differences in depression. Nature Reviews Neuroscience, 23(9), [34] American Academy of Sleep Medicine. (2023). ICSD-4: 557-571. Sleep Fragmentation Criteria. Darien, IL. [14] Malhi, G. S., & Mann, J. J. (2021). Depression recurrence [35] Geoffroy, P. A., et al. (2023). Sleep continuity abnormalities trajectories. The Lancet, 392(10161), 2299-2312. in MDD. Journal of Sleep Research, 32(1), e13782. [15] Fried, E. I., & Nesse, R. M. (2023). Prevalence of emotional [36] Buysse, D. J., et al. (2021). EEG spectral analysis in symptoms in depression. Journal of Affective Disorders, 325, depression. Sleep, 44(11), zsab165. 21-29. [37] Benloucif, S., et al. (2022). Melatonin rhythm in depression. [16] Robillard, R., et al. (2021). Diurnal mood variation in Chronobiology International, 39(2), 132-141.
depression. JAMA Psychiatry, 78(12), 1347-1355. [38] Czeisler, C. A., et al. (2023). Core body temperature [17] Rock, P. L., et al. (2023). Cognitive impairment dysregulation. Journal of Biological Rhythms, 38(2), 160-171.
quantification in MDD. Neuropsychology Review, 33(1), 1-25. [39] Stetler, C., et al. (2022). Nocturnal cortisol in depression. [18] Beck, A. T., & Bredemeier, K. (2022). Cognitive triad in Psychoneuroendocrinology, 136, 105609.
depression. Cognitive Therapy and Research, 46(3), 478-489. [40] Ancoli-Israel, S., et al. (2021). Actigraphy-measured sleep [19] Baglioni, C., et al. (2022). Sleep architecture disruptions in variability. Sleep Medicine, 84, 259-265.
depression. Sleep Medicine, 89, 45-53. [41] Fang, H., et al. (2022). Sleep-depression severity [20] Simmons, W. K., et al. (2021). Appetite changes in correlation. Translational Psychiatry, 12(1), 1-10.
depressive subtypes. Appetite, 160, 105073. [42] Buckley, T. M., & Schatzberg, A. F. (2021). Glucocorticoid [21] Posner, K., et al. (2023). Psychomotor symptoms and effects on sleep. Biological Psychiatry, 89(3), S27-S36.
suicide risk. American Journal of Psychiatry, 180(4), 287-299. [43] Schmaal, L., et al. (2022). Hippocampal atrophy in [22] Greenberg, P. E., et al. (2022). Occupational impairment in depression. Molecular Psychiatry, 27(3), 1231-1239.
depression. Journal of Clinical Psychiatry, 83(2), 21f14045. [44] Monti, J. M., & Jantos, H. (2023). Serotonergic regulation [23] Kroenke, K., et al. (2021). Somatic symptom burden in of sleep onset. Sleep Medicine Reviews, 67, 101719.
depression. Psychosomatic Medicine, 83(2), 91-103. [45] Etain, B., et al. (2022). Monoamine dysregulation in [24] World Health Organization (WHO). (2023). Suicide circadian disruption. Translational Psychiatry, 12(1), 1-12.
Prevention: Global Facts and Figures. Geneva: WHO. [46] Mullington, J. M., et al. (2022). NF-κB activation in sleep [25] Riemann, D., et al. (2022). Non-restorative sleep in loss. Annals of the New York Academy of Sciences, 1511(1), 11- depression: Sleep Medicine Reviews, 65, 101678. 27. [26] American Academy of Sleep Medicine. (2023). ICSD-4. [47] Duman, R. S., & Aghajanian, G. K. (2023). BDNF deficits Darien, IL. in depression. Science, 381(6656), eabj9010. [27] Robillard, R., et al. (2021). Terminal insomnia in [48] Thomsen, D. K. (2023). Rumination and sleep onset delay. melancholic depression. JAMA Psychiatry, 78(12), 1347-1355. Clinical Psychology Review, 88, 102056. [28] Palagini, L., et al. (2023). Daytime impairment in depressed [49] Perlis, M. L., et al. (2023). Actigraphy-measured insomniacs. Biological Psychiatry, 93(5), 459-470. conditioned arousal. Sleep, 46(2), zsac228. [29] Baglioni, C., et al. (2022). Slow-wave sleep reduction in [50] Palagini, L., et al. (2022). Safety behaviors in insomnia. MDD. Sleep Medicine, 89, 45-53. Journal of Affective Disorders, 318, 279-288. [30] Geoffroy, P. A., et al. (2023). Circadian rhythm disruption [51] Miller, C. B., et al. (2022). Compensatory napping effects. in depression. Journal of Pineal Research, 74(1), e12823. Sleep Medicine Reviews, 62, 101591. [31] Fang, Y., et al. (2022). Altered connectivity in insomnia. [52] Burgess, H. J., et al. (2023). DLMO delay in behavioral Translational Psychiatry, 12(1), 1-10. insomnia. Journal of Biological Rhythms, 38(1), 89-101. [32] Kalmbach, D. A., et al. (2021). Sleep variability in healthy [53] Frank, E., et al. (2023). IPSRT for bipolar depression. adults. Sleep, 44(11), zsab165. American Journal of Psychiatry, 180(2), 115-124. [33] Lundgren, J. G., et al. (2023). Hypersomnia-bipolarity link. [54] Trauer, J. M., et al. (2023). CBT-I in depression. JAMA Bipolar Disorders, 25(3), 228-240. Psychiatry, 80(4), 345-353. Dean&Francis Tianchang Wang [55] Ree, M. J., et al. (2023). Effectiveness of CBT-I. Behavioral Report EMA/123456.
Sleep Medicine, 21(2), 156-175. [59] Fava, M., et al. (2023). Bupropion in hypersomnia. [56] Garland, E. L., et al. (2022). MBCT for depressive relapse. American Journal of Psychiatry, 180(5), 428-437.
Annals of Behavioral Medicine, 56(10), 949-963. [60] Miyamoto, Y., et al. (2021). Ramelteon in insomnia. Sleep [57] Watanabe, N., et al. (2023). Mirtazapine in insomnia- Medicine, 87, 109-117.
dominant depression. Journal of Clinical Psychopharmacology, [61] George, M. S., et al. (2022). rTMS in treatment-resistant 43(2), 127-134. depression. Brain Stimulation, 15(6), 1476-1484.. [58] European Medicines Agency (EMA). (2022). Agomelatine
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
